# Osteonecrosis of the Hip and Bisphosphonate Treatment

> **NCT00781261** · PHASE2 · UNKNOWN · sponsor: **University of Sydney** · enrollment: 120 (estimated)

## Conditions studied

- Osteonecrosis

## Interventions

- **DRUG:** Zoledronic Acid
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00781261
- **Lead sponsor:** University of Sydney
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-08
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2013-01-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00781261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00781261, "Osteonecrosis of the Hip and Bisphosphonate Treatment". Retrieved via AI Analytics 2026-09-09 from https://api.ai-analytics.org/clinical/NCT00781261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*